USA: Hain Celestial: healthy choices (COMMENT)
By Datamonitor | 6 February 2004
Hain Celestial has posted another strong quarter, proving yet again that its healthy positioning within the food industry is both sustainable and on-target. Most recently it has chosen to focus on leveraging consumer interest in low-carb dieting - a prudent choice given the current Atkins-related hype.
just-food articles are only available to registered users and members.
Join now for increased access
There are various access options to choose from. All provide instant access to the latest news, insight and expert analysis.
If you’re already a member, login here.
Hain Celestial has posted another strong quarter, proving yet again that its healthy positioning within the food industry is both sustainable and on-target. Most recently it has chosen to focus on leveraging consumer interest in low-carb dieting - a prudent choice given the current Atkins-related hype.
- Unlimited access to all the latest global food news and insight
- Expert analysis that puts the news into context
- Exclusive interviews with leading industry figures
- Monthly management briefings with detailed analysis on hot topics
- Personalised RSS feeds and email newsletters
- 10-year archive of news, insight and intelligence
- Discounts on just-food market research
- Plus much more
If you’re already a member, login here
More articles related to this one
EUROPE: EU organic import control system delayed
The European Commission has asked European Union ministers that EU member states should continue to import organic meat and other foodstuffs freely for one more year until December 2006, whilst it establishes an EU control system.
USA: Lifeway Foods launches new organic pudding line
Functional food maker Lifeway Foods has announced the introduction of its new line of all natural, organic pudding under the name 'It's Pudding!.'
SWITZERLAND: Biotech company tests anti-obesity vaccine
Biotechnology company Cytos Biotechnology AG has announced the start of clinical trials of CYT009-GhrQb, a therapeutic vaccine for the treatment of obesity.
